Module 1 — Foundational Principles & General
Pharmacology
High-Yield MSN/NP-Level Prac ce Ques ons
Note: These ques ons are original and based on generalized pharmacology principles rather
than any specific textbook, test bank, or instructor resource. Calcula ons use standard
pharmacokine c rela onships and clinically simplified assump ons appropriate for board-style
prac ce.
I. Pharmacokine cs: Absorp on
Ques on 1 — First-Pass Metabolism
A 58-year-old pa ent with angina is prescribed a medica on that undergoes extensive hepa c
first-pass metabolism when swallowed. The pa ent reports that the medica on produces a
much stronger effect when administered sublingually than when taken orally. Which
pharmacokine c principle best explains this difference?
A. Sublingual administra on increases renal clearance of the medica on.
B. Sublingual administra on bypasses much of hepa c first-pass metabolism.
C. Sublingual administra on increases plasma protein binding.
D. Sublingual administra on converts the medica on into an ac ve metabolite.
Answer: B
Clinical Ra onale
The correct answer is B. Drugs absorbed through the oral mucosa can enter the systemic
circula on while substan ally bypassing gastrointes nal absorp on and hepa c first-pass
metabolism. First-pass metabolism can markedly reduce the frac on of an orally administered
dose that reaches systemic circula on, known as bioavailability (F).
,This dis nc on is clinically important when rapid onset or higher systemic exposure is desired.
Sublingual administra on may also be advantageous when gastrointes nal absorp on is
unreliable.
A is incorrect: Renal clearance occurs a er the drug reaches systemic circula on and
does not explain the increased effect immediately a er sublingual administra on.
C is incorrect: Protein binding affects distribu on and free drug concentra on; it is not
the primary reason for greater sublingual bioavailability.
D is incorrect: Sublingual administra on does not inherently convert a drug into an
ac ve metabolite. Metabolic ac va on is a separate pharmacokine c process.
Ques on 2 — Passive Diffusion
A 42-year-old pa ent receives an oral medica on that is highly lipid soluble and predominantly
nonionized at physiologic pH. Which mechanism most likely accounts for its movement across
intes nal epithelial membranes?
A. ATP-dependent ac ve transport against a concentra on gradient
B. Vesicular endocytosis of the medica on
C. Passive diffusion down an electrochemical gradient
D. Filtra on through renal glomerular pores
Answer: C
Clinical Ra onale
The correct answer is C. Many medica ons cross biological membranes primarily by passive
lipid diffusion. Lipid solubility, membrane permeability, molecular size, and degree of ioniza on
influence this process. A highly lipid-soluble, rela vely nonionized drug readily par ons into
cell membranes and moves from an area of higher concentra on toward lower concentra on
without requiring cellular energy.
, A is incorrect: Ac ve transport requires a carrier and energy and is especially relevant
for selected nutrients and drugs that resemble endogenous substrates.
B is incorrect: Endocytosis is not the usual mechanism for absorp on of conven onal
small-molecule medica ons.
D is incorrect: Glomerular filtra on is a mechanism of renal elimina on, not intes nal
drug absorp on.
Ques on 3 — Gastric pH and Absorp on
A pa ent taking an orally administered weakly acidic medica on begins chronic proton-pump
inhibitor therapy. Which change could occur because of the increased gastric pH?
A. Altered ioniza on of the weak acid, poten ally changing its absorp on
B. Complete preven on of hepa c metabolism
C. Immediate increase in renal tubular secre on
D. Elimina on of all protein binding
Answer: A
Clinical Ra onale
The correct answer is A. Gastric and intes nal pH can influence drug ioniza on, which can affect
membrane permeability and therefore absorp on. Weak acids and weak bases behave
differently as environmental pH changes. The Henderson-Hasselbalch rela onship helps predict
the propor on of ionized versus nonionized drug.
The clinical effect depends on where the medica on is primarily absorbed and on its
physicochemical characteris cs; therefore, increased gastric pH does not universally increase or
decrease absorp on.
B is incorrect: Gastric pH does not eliminate hepa c biotransforma on.
, C is incorrect: Renal tubular secre on is an elimina on process involving renal transport
systems and is not directly caused by increased gastric pH.
D is incorrect: Protein binding occurs primarily in plasma and ssues and is independent
of the basic change described.
Ques on 4 — Bioavailability
A new oral medica on has a bioavailability of 0.40. The prescriber wants systemic exposure
equivalent to a 40-mg intravenous dose. Assuming equivalent distribu on and no dose-
dependent kine cs, which oral dose is theore cally required?
A. 16 mg
B. 40 mg
C. 80 mg
D. 100 mg
Answer: D
Clinical Ra onale
The correct answer is D.
For an IV dose, systemic availability is essen ally 100%. For the oral route:
[
\text{Systemically available dose} = \text{oral dose} \ mes F
]
Therefore:
[
40 = \text{oral dose} \ mes 0.40
]
Pharmacology
High-Yield MSN/NP-Level Prac ce Ques ons
Note: These ques ons are original and based on generalized pharmacology principles rather
than any specific textbook, test bank, or instructor resource. Calcula ons use standard
pharmacokine c rela onships and clinically simplified assump ons appropriate for board-style
prac ce.
I. Pharmacokine cs: Absorp on
Ques on 1 — First-Pass Metabolism
A 58-year-old pa ent with angina is prescribed a medica on that undergoes extensive hepa c
first-pass metabolism when swallowed. The pa ent reports that the medica on produces a
much stronger effect when administered sublingually than when taken orally. Which
pharmacokine c principle best explains this difference?
A. Sublingual administra on increases renal clearance of the medica on.
B. Sublingual administra on bypasses much of hepa c first-pass metabolism.
C. Sublingual administra on increases plasma protein binding.
D. Sublingual administra on converts the medica on into an ac ve metabolite.
Answer: B
Clinical Ra onale
The correct answer is B. Drugs absorbed through the oral mucosa can enter the systemic
circula on while substan ally bypassing gastrointes nal absorp on and hepa c first-pass
metabolism. First-pass metabolism can markedly reduce the frac on of an orally administered
dose that reaches systemic circula on, known as bioavailability (F).
,This dis nc on is clinically important when rapid onset or higher systemic exposure is desired.
Sublingual administra on may also be advantageous when gastrointes nal absorp on is
unreliable.
A is incorrect: Renal clearance occurs a er the drug reaches systemic circula on and
does not explain the increased effect immediately a er sublingual administra on.
C is incorrect: Protein binding affects distribu on and free drug concentra on; it is not
the primary reason for greater sublingual bioavailability.
D is incorrect: Sublingual administra on does not inherently convert a drug into an
ac ve metabolite. Metabolic ac va on is a separate pharmacokine c process.
Ques on 2 — Passive Diffusion
A 42-year-old pa ent receives an oral medica on that is highly lipid soluble and predominantly
nonionized at physiologic pH. Which mechanism most likely accounts for its movement across
intes nal epithelial membranes?
A. ATP-dependent ac ve transport against a concentra on gradient
B. Vesicular endocytosis of the medica on
C. Passive diffusion down an electrochemical gradient
D. Filtra on through renal glomerular pores
Answer: C
Clinical Ra onale
The correct answer is C. Many medica ons cross biological membranes primarily by passive
lipid diffusion. Lipid solubility, membrane permeability, molecular size, and degree of ioniza on
influence this process. A highly lipid-soluble, rela vely nonionized drug readily par ons into
cell membranes and moves from an area of higher concentra on toward lower concentra on
without requiring cellular energy.
, A is incorrect: Ac ve transport requires a carrier and energy and is especially relevant
for selected nutrients and drugs that resemble endogenous substrates.
B is incorrect: Endocytosis is not the usual mechanism for absorp on of conven onal
small-molecule medica ons.
D is incorrect: Glomerular filtra on is a mechanism of renal elimina on, not intes nal
drug absorp on.
Ques on 3 — Gastric pH and Absorp on
A pa ent taking an orally administered weakly acidic medica on begins chronic proton-pump
inhibitor therapy. Which change could occur because of the increased gastric pH?
A. Altered ioniza on of the weak acid, poten ally changing its absorp on
B. Complete preven on of hepa c metabolism
C. Immediate increase in renal tubular secre on
D. Elimina on of all protein binding
Answer: A
Clinical Ra onale
The correct answer is A. Gastric and intes nal pH can influence drug ioniza on, which can affect
membrane permeability and therefore absorp on. Weak acids and weak bases behave
differently as environmental pH changes. The Henderson-Hasselbalch rela onship helps predict
the propor on of ionized versus nonionized drug.
The clinical effect depends on where the medica on is primarily absorbed and on its
physicochemical characteris cs; therefore, increased gastric pH does not universally increase or
decrease absorp on.
B is incorrect: Gastric pH does not eliminate hepa c biotransforma on.
, C is incorrect: Renal tubular secre on is an elimina on process involving renal transport
systems and is not directly caused by increased gastric pH.
D is incorrect: Protein binding occurs primarily in plasma and ssues and is independent
of the basic change described.
Ques on 4 — Bioavailability
A new oral medica on has a bioavailability of 0.40. The prescriber wants systemic exposure
equivalent to a 40-mg intravenous dose. Assuming equivalent distribu on and no dose-
dependent kine cs, which oral dose is theore cally required?
A. 16 mg
B. 40 mg
C. 80 mg
D. 100 mg
Answer: D
Clinical Ra onale
The correct answer is D.
For an IV dose, systemic availability is essen ally 100%. For the oral route:
[
\text{Systemically available dose} = \text{oral dose} \ mes F
]
Therefore:
[
40 = \text{oral dose} \ mes 0.40
]
